Precision Rifampin Dosing for TB
Part of Infections clinical trials.
This study tests whether giving a personalized dose of rifampin (a key TB medicine) can improve treatment. It is for people with active TB that is sensitive to rifampin, and it involves frequent blood and urine tests to measure drug levels.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 3 years old or older.
- You have active TB that is sensitive to the antibiotic rifampin (confirmed by a lab test).
- You are starting a standard four-drug TB treatment regimen (isoniazid, rifampin, pyrazinamide, ethambutol).
- You weigh at least 10 kilograms (22 pounds).
- You live in a specific area where the TB clinic can follow up with you.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests personalized TB treatment schedules based on your individual risk factors. Researchers want to see if matching treatment intensity to your specific situation helps cure TB while minimizing side effects.
This trial tests a shorter treatment for children with tuberculosis (TB) that is not drug-resistant. It aims to find out if a shorter regimen works as well as the standard longer one, making treatment easier for children and their families.
This study is testing whether a shorter course of TB medicine works just as well as the standard longer treatment for children with drug-susceptible tuberculosis. It aims to make treatment easier for families.
This study tests shorter treatments for tuberculosis (TB) and TB infection using the drug rifapentine. If you have TB or are at risk of developing it, this trial may help you finish treatment faster.
This trial tests whether higher or standard doses of the antibiotic rifampicin work better for treating pulmonary tuberculosis (a lung infection). You may benefit if you are starting TB treatment and have not had a bad reaction to rifampicin before.
This trial tests a personalized approach to dosing the TB medicine rifampin. By using a computer model based on your individual factors, doctors hope to find the right dose for you, which may improve treatment outcomes.
Hear when a new Tuberculosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.